FIELD: biotechnology.
SUBSTANCE: invention relates to a method of increasing the phagocytic activity of macrophages. The method involves exposing macrophages to graphene oxide nanoparticles obtained by electrochemical exfoliation of working electrodes from highly oriented pyrolytic graphite and diluted with phosphate-buffered saline to obtain a graphene oxide concentration of 1 mg/ml, while the resulting suspension is added to the cell monolayer of macrophages at a final concentration of 2 μg/ml of medium to prevent cell necrosis, cells are cultured in the presence of graphene oxide for 2 hours, after which they are washed.
EFFECT: invention is effective for increasing the effectiveness of biotechnological vaccines based on macrophages.
1 cl, 1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MODIFIED MONOCYTES/MACROPHAGES EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND THEIR APPLICATIONS | 2016 |
|
RU2766690C2 |
| METHOD FOR ASSESSING PHAGOCYTIC ACTIVITY OF NEUTROPHILS | 2023 |
|
RU2824345C1 |
| METHOD OF SUBCUTANEOUS TRANSPLANT GROWTH INHIBITION OF EXPERIMENTAL HUMAN GLIOBLASTOMA U-87, TRANSPLANTED TO IMMUNODEFICIENT MICE Nu/J | 2019 |
|
RU2717218C1 |
| METHOD OF SELECTING MEDICINAL PRODUCTS FOR PHARMACOLOGICAL INDUCTION OF MITOCHONDRIAL DYSFUNCTION IN MACROPHAGES FOR ANTITUMOR THERAPY | 2023 |
|
RU2810558C1 |
| NK CELL LINE EXPRESSING PSMA-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND SECRETING CD47/SIRPA INTERACTION BLOCKER | 2020 |
|
RU2757353C1 |
| METHOD OF TUMOUR GROWTH INHIBITION BASED ON IN VITRO REPROGRAMMING MACROPHAGES ON M1 PHENOTYPE WITH HIGH ABILITY OF NITRIC OXIDE PRODUCTION IN EXPERIMENT | 2015 |
|
RU2599545C1 |
| HUMAN MELANOMA CELL LINE PG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395570C1 |
| HUMAN MELANOMA CELL LINE ILG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395574C1 |
| HUMAN MELANOMA CELL LINE IG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395572C1 |
| HUMAN MELANOMA CELL LINE 26G WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395571C1 |
